FDA Approved: ZOLMIPTRIPTAN — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approves Glenmark's ZOLMIPTRIPTAN (zolmitriptan) as a generic under an original ANDA, enabling market entry for acute treatment of migraine attacks.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• ZOLMIPTRIPTAN (Zolmitriptan)

Snippet

ORIG AP for ZOLMIPTRIPTAN (ZOLMITRIPTAN)